The FDA warnings that apply to their medications
A person should always consult a doctor before starting or switching to a GLP-1
How often can I receive the injections
doi: 10.1196/annals.1447.049 47 HirotaKDuarteJHVeldhoenMHornsbyELiYCuaDJet al
Though with similar effects as some pre-existing drugs (semaglutide, liraglutide, exenatide, etc.) targeting diabetes and obesity, tirzepatide is considered a first-in-class medication for demonstrating action on both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors
Statements Author contributions Q-WC: Formal analysis, Investigation, Methodology, Validation, Visualization, Writing original draft, Writing review and editing